Accutane Class Action Lawsuit Certification Denied in Canada

An attempt to establish a class action lawsuit in Canada for bowel problems from Accutane has been rejected, after the judge indicated that plaintiffs failed to establish evidence of a link between the acne medication and inflammatory bowel disease (IBD).

Late last month, Canadian Judge Manon Savard refused to certify an Accutane class action lawsuit brought against Hoffmann-La Roche Ltd. by Yann Lebrasseur, who was seeking to include all citizens of Quebec that experienced bowel injuries.

Lebrasseur claimed that Roche, the manufacturer of Accutane, failed to adequately warn patients and the medical community about the risk of IBD, which could include ulcerative colitis or Crohn’s disease.

Did You Know?

Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

According to a report by, the judge determined that the plaintiff failed to show how the label warnings were inadequate and failed to show a link between Accutane and IBD in medical literature.

Roche faces thousands of similar Accutane bowel disease lawsuits in the United States, and several juries in this country have already returned multi-million dollar damage awards as a result of the drug makers failure to adequately warn consumers or the medical community about the known risk of bowel damage.

Known generically as isotretinoin, Accutane has been used by more than 16 million people worldwide since it was first introduced in the early 1980s. Roche removed the brand name version of the medication from the market in the U.S., citing the mounting costs associated with litigation over Accutane and competition from generic equivalents.

More than 7,000 of the Accutane cases pending in the United States are centralized in New Jersey state court, before Judge Carol E. Higbee. Last year, a New Jersey jury awarded $9 million to two Accutane plaintiffs, finding that the company failed to properly warn doctors and patients of the risk of IBD.


"*" indicates required fields

Share Your Comments

I authorize the above comments be posted on this page*

Have Your Comments Reviewed by a Lawyer

Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Philips CPAP Lawsuit Filing Deadlines May Be Approaching in Some Claims
Philips CPAP Lawsuit Filing Deadlines May Be Approaching in Some Claims (Posted 2 days ago)

Lawyers are working to register and file Philips CPAP lawsuits, as the manufacturer may argue the June 14 anniversary of a massive recall triggered the start of the statute of limitations in certain states